Kingsview Wealth Management LLC grew its position in Colgate-Palmolive (NYSE:CL – Free Report) by 4.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,444 shares of the company’s stock after acquiring an additional 644 shares during the period. Kingsview Wealth Management LLC’s holdings in Colgate-Palmolive were worth $1,603,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC increased its holdings in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at $53,000. Finally, Prospera Private Wealth LLC bought a new position in Colgate-Palmolive during the third quarter worth $64,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock opened at $95.34 on Tuesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The stock has a market capitalization of $77.89 billion, a P/E ratio of 27.32, a price-to-earnings-growth ratio of 3.39 and a beta of 0.42. The stock has a fifty day moving average of $97.90 and a 200-day moving average of $98.58.
Colgate-Palmolive Announces Dividend
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on CL shares. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. TD Cowen cut their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. UBS Group upped their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Finally, Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $105.11.
Check Out Our Latest Stock Report on CL
Insider Activity
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.37% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Buy P&G Now, Before It Sets A New All-Time High
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Compound Interest and Why It Matters When Investing
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Investing In Preferred Stock vs. Common Stock
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.